Since its establishment in November 2004, the Sidney Kimmel Comprehensive Cancer Center (SKCCC) Microarray Core has provided services with affordable rates and flexibility in a timely manner to Cancer Center members across the Hopkins Medical Campus. The Core operates such that it supplies platforms not primarily offered by other array Cores throughout the School of Medicine and it is closely linked, for high level computational needs of users, to the new Bioinformatics Core in the Cancer Center. Since the last renewal, the Core has added to its full Agilent expression and DNA platforms, lllumina Infinium BeadChip technology including the Infinium platform for genome wide, promoter region DNA methylation. Thus, using both Agilent and lllumina technologies, the Core now offers assays for gene expression, micro RNA expression, DNA copy number variation, ChlP-on-chip, and genome-wide DNA methylation profiling. SNP analysis is also possible with the Core's current platforms. The probe density on the arrays and level of sample throughput have been increased significantly since the last renewal to efficiently meet the increased research needs of Cancer Center members. The Core's services also include DNA and RNA extraction from submitted samples, quality assessment of all submitted RNA and DNA samples, bisulfate treatment and quality control assessment of DNA for the Infinium methylation platform, and experiment design consultation. Real time PCR confirmation of expression array data is also provided. Preliminary data analysis and help in using software for data analysis are offered. The Core participates in computational biology seminars arranged by the Bioinformatics Core and arranges presentations by Agilent, lllumina, and other array offering companies to all Cancer Center and others throughout the School of Medicine. Lay: The Microarray Core provides different DNA microarray solutions to meet the needs of genomic research as well as related services including sample isolation and software training for data analysis.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Center Core Grants (P30)
Project #
Application #
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Johns Hopkins University
United States
Zip Code
Zeidner, Joshua F; Zahurak, Marianna; Rosner, Gary L et al. (2015) The evolution of treatment strategies for patients with chronic myeloid leukemia relapsing after allogeneic bone marrow transplant: can tyrosine kinase inhibitors replace donor lymphocyte infusions? Leuk Lymphoma 56:128-34
Penet, Marie-France; Shah, Tariq; Bharti, Santosh et al. (2015) Metabolic imaging of pancreatic ductal adenocarcinoma detects altered choline metabolism. Clin Cancer Res 21:386-95
Sharabi, Andrew B; Nirschl, Christopher J; Kochel, Christina M et al. (2015) Stereotactic Radiation Therapy Augments Antigen-Specific PD-1-Mediated Antitumor Immune Responses via Cross-Presentation of Tumor Antigen. Cancer Immunol Res 3:345-55
Peltonen, Karita; Colis, Laureen; Liu, Hester et al. (2014) A targeting modality for destruction of RNA polymerase I that possesses anticancer activity. Cancer Cell 25:77-90
DeZern, Amy E; Guinan, Eva C (2014) Aplastic anemia in adolescents and young adults. Acta Haematol 132:331-9
Paller, Channing J; Wissing, Michel D; Mendonca, Janet et al. (2014) Combining the pan-aurora kinase inhibitor AMG 900 with histone deacetylase inhibitors enhances antitumor activity in prostate cancer. Cancer Med 3:1322-35
Maldonado, Leonel; Teague, Jessica E; Morrow, Matthew P et al. (2014) Intramuscular therapeutic vaccination targeting HPV16 induces T cell responses that localize in mucosal lesions. Sci Transl Med 6:221ra13
Schweizer, Michael T; Antonarakis, Emmanuel S (2014) Chemotherapy and its evolving role in the management of advanced prostate cancer. Asian J Androl 16:334-40
Huang, Peng; Ou, Ai-hua; Piantadosi, Steven et al. (2014) Formulating appropriate statistical hypotheses for treatment comparison in clinical trial design and analysis. Contemp Clin Trials 39:294-302
Bhatnagar, Akrita; Wang, Yuchuan; Mease, Ronnie C et al. (2014) AEG-1 promoter-mediated imaging of prostate cancer. Cancer Res 74:5772-81

Showing the most recent 10 out of 357 publications